Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01365195 · ClinicalTrials.gov registry record · Phase 4
Effect of Ketamine on Postoperative Clinical Outcomes
A Phase 4 study, sponsored by Cedars-Sinai Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT01365195 is a Phase 4 study that was terminated before completion, run by Cedars-Sinai Medical Center. The registered enrollment target is 21 participants.
The verdict
NCT01365195, a Phase 4 study, was terminated before completion, sponsored by Cedars-Sinai Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate the effectiveness of ketamine as an analgesic adjuvant in decreasing the narcotic (opioids) analgesics during surgery, on pain management and on the later recovery after surgery in patients undergoing colorectal surgery.
Interventions
- DRUG Placebo
- DRUG Ketamine high-dose
- DRUG Ketamine low-dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01365195
The ClinicalTrials.gov registry entry for NCT01365195 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01365195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01365195 about?
NCT01365195 is a clinical study titled "Effect of Ketamine on Postoperative Clinical Outcomes". The purpose of this research is to evaluate the effectiveness of ketamine as an analgesic adjuvant in decreasing the narcotic (opioids) analgesics during surgery, on pain management and on the later recovery after surgery in patients undergoing colorectal surgery.
What is the current status of trial NCT01365195?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2011-05. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01365195?
The interventions under investigation include: Placebo (DRUG), Ketamine high-dose (DRUG), Ketamine low-dose (DRUG).
Who is sponsoring clinical trial NCT01365195?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.